Immunocore Holdings plc Operating Lease, Right-of-Use Asset in USD from Q4 2022 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Immunocore Holdings plc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2022 to Q3 2025.
  • Immunocore Holdings plc Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2025 was $39.4M, a 0.69% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)

Immunocore Holdings plc Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $39.4M -$275K -0.69% Sep 30, 2025 10-Q 2025-11-06
Q2 2025 $39.4M +$6.99M +21.6% Jun 30, 2025 10-Q 2025-08-07
Q1 2025 $38.1M +$5.31M +16.2% Mar 31, 2025 10-Q 2025-05-07
Q4 2024 $37.6M +$4.12M +12.3% Dec 31, 2024 10-Q 2025-11-06
Q3 2024 $39.7M +$34.2M +621% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $32.4M Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $32.8M Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $33.5M +$2.58M +8.33% Dec 31, 2023 10-K 2025-02-26
Q3 2023 $5.5M Oct 31, 2023 10-K 2024-02-28
Q4 2022 $30.9M Dec 31, 2022 10-K 2024-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.